AQP4 and stroke disorder: Finally, clinical studies should incorporate AQP4-related endpoints, for instance, genotyping stroke patients for AQP4 SNPs or measuring AQP4 in biofluids to further validate AQP4 as a therapeutic target and stratify patients who might benefit from AQP4-directed treatments or classical treatments.